-
Lupin’s Nagpur facility inspection concludes with no observation
financialexpress
September 17, 2018
This inspection was a product specific pre-approval inspection
-
Lupin receives FDA approval for generic Atovaquone Oral Solution USP
financialexpress
September 17, 2018
Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic version of GlaxoSmithKline LLC’s Mepron Oral Suspension, 750 mg/5 mL
-
Lupin to train over 1,000 graduates for pharma industry
financialexpress
September 10, 2018
Mumbai-headquartered Lupin has estimated that by the year 2020 they would be spending almost INR 20 crore on this programme
-
US FDA inspects Lupin’s Tarapur API facility
financialexpress
September 04, 2018
Rules out presence of NDMA impurity in co’s Valsartan, Losartan and Irbesartan APIs
-
Lupin receives FDA approval for generic Potassium Chloride Oral Solution USP
financialexpress
September 03, 2018
It is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis
-
Lupin gets US FDA nod to market postherpetic neuralgia drug
expressbpd
August 30, 2018
Lupin has announced that it has received approval from the US health regulator to market its generic Gabapentin tablets used for treatment of postherpetic neuralgia in the American market.
-
Lupin launches contraceptive drug in US
August 28, 2018
Lupin has launched Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg (EQ Beyaz), having received an approval from the United States Food and Drug Administration (US FDA) earl
-
Lupin enters dermatology segment in Brazil
expressbpd
August 27, 2018
The company enters Brazil under the Lupin high-end skin science umbrella
-
Lupin recalls over 11,000 bottles of hypertension drug in US
expressbpd
August 24, 2018
The product was distributed to distributors, mail order pharmacy and supermarkets throughout the US, it added
-
Lupin receives tentative FDA approval for generic Nudovra
expressbpd
August 23, 2018
Pharma major Lupin announced that it has received tentative approval for its Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest Tablets.....